Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Novartis HQ

Novartis eye drug wins wider European licence

June 6, 2011 Sales and Marketing Lucentis, Novartis

Novartis’ Lucentis has been approved in Europe to treat people suffering from vision loss due to macular oedema secondary to …
News

BMS and Roche to team up in melanoma

June 3, 2011 Sales and Marketing BMS, Roche, melanoma, oncology

Bristol-Myers Squibb and Roche are to use two of their drugs in an exploratory phase I/II study a bid to …
News

UNICEF highlights price differences for vaccines

June 2, 2011 Sales and Marketing Unicef, developing world, vaccines

A large disparity in the cost of vaccines has been revealed by UNICEF. The United Nations Children’s Fund charity has …
News

AstraZeneca to stop paying for international conference trips

June 2, 2011 Medical Communications, Sales and Marketing AstraZeneca, congresses, ethics

AstraZeneca will no longer pay for doctors to attend international conferences. The move is the latest development in the industry’s …
News
Pfizer HQ

Pfizer files new kidney cancer drug

June 2, 2011 Sales and Marketing Nexavar, Pfizer, rcc

Pfizer has filed its kidney cancer drug axitinib in the EU after impressive head-head- trials with Bayer’s Nexavar. Pfizer is …
News
Anna Dixon

Reforms will weaken health service accountability

June 1, 2011 Sales and Marketing NHS reform, king's fund

The government has received yet more unwelcome news on health policy with a leading think tank warning its reforms will …
News

J&J aims for Japanese pharma expansion

May 27, 2011 Research and Development, Sales and Marketing J&J, JJ

Johnson & Johnson has identified Japan as a key growth market for its pharma business as it outlines its strategic …
News
Jim Easton

Pharma faces ‘trench warfare’ with NHS

May 26, 2011 Sales and Marketing Cost cutting, NHS, prescribing

The competing interests of the NHS and the pharma industry could end in trench warfare, a leading NHS figure has …
News

NICE to appraise hep C drugs Victrelis and telaprevir

May 26, 2011 Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir

NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …
News

GSK’s Trobalt launched in UK

May 25, 2011 Sales and Marketing GlaxoSmithKline, Trobalt, epilepsy, retigabine

GSK has launched its new epilepsy treatment Trobalt in the UK. Trobalt (retigabine) is as adjunctive treatment of partial onset …
News
Roche's MabThera’s (rituximab)

NICE U-turn on Roche’s MabThera

May 25, 2011 Sales and Marketing MabThera, NICE, Roche

NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …
News

J&J and Vertex’s hep C drug Incivek approved by FDA

May 24, 2011 Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir

The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …
News

CHMP roundup

May 24, 2011 Sales and Marketing CHMP, EMA, Fampyra, Vibativ, Victrelis, Xgeva, Yervoy

The latest products to be recommended for European approval include MSD’s Victrelis, Astellas Pharma Europe’s Vibativ, Amgen Europe’s Xgeva and …
News

Pfizer and BMS to give Eliquis a rolling launch in Europe

May 24, 2011 Sales and Marketing Eliquis, Pfizer, apixaban, atrial fibrillation

Pfizer and Bristol-Myers Squibb are gearing up to give their new oral anticoagulant Eliquis a rolling launch in Europe, starting …
News

European recommendation for GSK’s lupus drug Benlysta

May 23, 2011 Sales and Marketing Benlysta, CHMP, GlaxoSmithKline, Lupus

GlaxoSmithKline’s first-in-class lupus drug Benlysta has been given a major boost by regulators in the European Union. The European Medicines …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026